Sort by
Refine Your Search
-
data. We have developed in vivo single-cell CRISPR technologies to screen for dozens of molecular factors in vivo during developmental and disease. These technologies are a game-changer in the speed
-
includes https://doi.org/10.1101/2025.0... and https://doi.org/10.64898/2025.... Profile You have: An MSc (or equivalent) in structural biology, cell biology, biophysics, bioengineering
-
prodromal cohorts and link them to clinical readouts and α-synuclein reactivity. Use cutting-edge single-cell and immune-profiling approaches, linked to clinical phenotyping, to discover early biomarkers and
-
that regulate plant development and physiology, including adaptation to environmental stresses. They are synthesized in the cell interior and exported across the plasma membrane to bind receptors at the cell
-
the development of genetic autoinflammatory diseases. Using techniques in cell biology, molecular biology and biophysics you will investigate how loss of function of the RNA editing enzyme ADAR1 causes the human
-
. In the Motivation section of the application form, please enter only the name of the PhD project and the supervisor you wish to apply for. You can find the list of available projects here https
-
and Saeys teams. In this research project you will develop and apply algorithms to link clinical phenotypes of metastasis to molecular phenotypes in mouse models. It is known that metastases exhibit
-
developing genetic risk scores as biomarkers for neurological disorders. The Rademakers lab leads cutting-edge research into risk genes and molecular mechanisms in Frontotemporal Dementia (FTD), while
-
prodromal cohorts and link them to clinical readouts and α-synuclein reactivity. Use cutting-edge single-cell and immune-profiling approaches, linked to clinical phenotyping, to discover early biomarkers and